CLGN CollPlant Biotechnologies Ltd: institutional ownership and insider trading
13 funds reported holding $864K of CollPlant Biotechnologies Ltd in their latest 13F filings; in Q2 2026 funds net bought $49.7K, with 1 new positions and 6 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
Famous investors holding CLGN
- Renaissance Technologies (Renaissance Technologies): $21.5K, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $18.7K, 0.0% of the portfolio
Largest institutional holders of CLGN
- AMH Equity Ltd — $538K
- VILLERE ST DENIS J & CO LLC — $212K
- BROWN ADVISORY INC — $36.5K
- RENAISSANCE TECHNOLOGIES LLC — $21.5K
- Pathstone Holdings, LLC — $19.9K
- CITADEL ADVISORS LLC — $18.7K
- Legacy Wealth Managment, LLC/ID — $8.09K
- WATERS PARKERSON & CO., LLC — $4.62K
- XTX Topco Ltd — $4.56K
- UBS Group AG (UBS) — $361
5%+ owners
- The Loewenbaum 1992 Trust: 17.5% (Schedule 13D/A, filed Aug 21, 2026)
- George Walter Loewenbaum: 9.9% (Schedule 13D/A, filed Nov 7, 2025)
- Ami Sagy: 5.7% (Schedule 13G, filed Oct 8, 2026)